We are not all equal when it comes to radiation: Evaluating patients' individual radiosensitivity allows clinicians to optimize their radiotherapy treatment and improve their patients’ quality of life.
A simple blood sampling or a small skin biopsy is performed by the physician. We can then isolate and cultivate the cells of interest from this sample in order to carry out our predictive tests.
We provide the physician with a detailed report, which is a decision-making tool in itself. Physicians can then rely on this report to adapt patient care.
Our solutions optimize radiotherapy treatments’ efficiency while avoiding toxicities for patients.
Our R&D unit aims to conceive, develop and optimize innovative tests, to make them accessible to everyone.